Open access
Jun 2026
Comprehensive pan-cancer analysis and experimental validation of mitotic arrest defective 2-like 1 (MAD2L1) in colorectal cancer
MAD2L1 is a potential biomarker for diagnosis, prognosis, immune response, and drug sensitivity in pan-cancer, including CRC and facilitates tumor progression through a lncRNA-miRNA–miRNA network and regulates proliferation and apoptosis via DNA replication and cell cycle pathways.
Qing-Qing Wu, Zhuang-Zhuang Tian, Li-Yu Cao
· BioImpacts · 0 citations